The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer (original) (raw)
Ackler S, Ahmad S, Tobias C, Johnson MD, Glazer RI . (2002). Delayed mammary gland involution in MMTV-AKT1 transgenic mice. Oncogene21: 198–206. ArticleCASPubMed Google Scholar
Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA . (2003). Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol201: 229–237. ArticleCASPubMed Google Scholar
Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R et al. (2003). Overexpression of Akt2/protein kinase B_β_ leads to up-regulation of _β_1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res63: 196–206. CASPubMed Google Scholar
Attwell S, Roskelley C, Dedhar S . (2000). The integrin-linked kinase (ILK) suppresses anoikis. Oncogene19: 3811–3815. ArticleCASPubMed Google Scholar
Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S et al. (2004). The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther3: 772–775. ArticleCASPubMed Google Scholar
Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA et al. (1995). Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer64: 280–285. ArticleCASPubMed Google Scholar
Bravou V, Klironomos G, Papadaki E, Taraviras S, Varakis V . (2006). ILK over-expression in human colon cancer progression correlates with activation of _β_-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway. J Pathol208: 91–99. ArticleCASPubMed Google Scholar
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell96: 857–868. ArticleCASPubMed Google Scholar
Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T et al. (2001). Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene. Genes Dev15: 2203–2208. ArticleCASPubMedPubMed Central Google Scholar
Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw III EB et al. (2001a). Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB_β_). Science292: 1728–1731. ArticleCASPubMed Google Scholar
Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ . (2001b). Akt1/PKB_α_ is required for normal growth but dispensible for maintenance of glucose homeostasis in mice. J Biol Chem276: 38349–38352. ArticleCASPubMed Google Scholar
Chung DH, Lee JI, Kook MC, Kim JR, Kim SH, Choi EY et al. (1998). ILK (beta1-integrin-linked protein kinase): a novel immunohistochemical marker for Ewing's sarcoma and primitive neuroectodermal tumour. Virchows Arch433: 113–117. ArticleCASPubMed Google Scholar
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA . (1995). Inhibition of glycogen cynthase kinase-3 by insulin mediated protein kinase B. Nature378: 785–789. ArticleCASPubMed Google Scholar
Dahia PL, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T et al. (1997). Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res57: 4710–4713. CASPubMed Google Scholar
Dai DL, Makretsov N, Campos EI, Huang C, Zhou Y, Huntsman D et al. (2003). Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Clin Cancer Res9: 4409–4414. CASPubMed Google Scholar
D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B et al. (2000). The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem275: 32649–32657. ArticleCASPubMed Google Scholar
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y et al. (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell91: 231–241. ArticleCASPubMed Google Scholar
del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science278: 687–689. ArticleCASPubMed Google Scholar
Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S . (1998). Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA95: 11211–11216. ArticleCASPubMedPubMed Central Google Scholar
Deprez J, Vertommen D, Alessi DR, Hue L, Rider MH . (1997). Phosphorylation and activation of heart glucose 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascade. J Biol Chem272: 17269–17275. ArticleCASPubMed Google Scholar
Diehl JA, Cheng M, Roussel MF, Sherr CJ . (1998). Glycogen synthase kinase-3_β_ regulates cyclin D1 proteolysis and subcellular localization. Genes Dev12: 3499–3511. ArticleCASPubMedPubMed Central Google Scholar
Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS et al. (2005). Role for Akt3/protein kinase B_γ_ in attainment of normal brain size. Mol Cell Biol25: 1869–1878. ArticleCASPubMedPubMed Central Google Scholar
Edwards LA, Thiessen B, Dragowska WH, Daynard T, Bally MB, Dedhar S . (2005). Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene24: 3596–3605. ArticleCASPubMed Google Scholar
Garcia JM, Silva JM, Dominguez G, Gonzalez R, Navarro A, Carretero L et al. (1999). Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat57: 237–243. ArticleCASPubMed Google Scholar
Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW et al. (2001). Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res7: 1987–1991. CASPubMed Google Scholar
Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J et al. (1996). Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature379: 91–96. ArticleCASPubMed Google Scholar
Hennessy BT, Smith DL, Ram PT, Lu T, Mills GB . (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Disc4: 988–1004. ArticleCAS Google Scholar
Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ . (2001). Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol21: 2203–2212. ArticleCASPubMedPubMed Central Google Scholar
Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ . (2004). Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res64: 3171–3178. ArticleCASPubMed Google Scholar
Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N et al. (2005). Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol171: 1023–1034. ArticleCASPubMedPubMed Central Google Scholar
Kane LP, Shapiro VS, Stokoe D, Weiss A . (1999). Induction of NF-_κ_B by the Akt/PKB kinase. Curr Biol9: 601–604. ArticleCASPubMed Google Scholar
Kang S, Bader AG, Vogt PK . (2005). Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA102: 802–807. ArticleCASPubMedPubMed Central Google Scholar
Kawakami Y, Nishimoto H, Kitaura J, Maeda-Yamamoto M, Kato RM, Littman DR et al. (2004). Protein kinase C _β_II regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J Biol Chem279: 47720–47725. ArticleCASPubMed Google Scholar
Kohn AD, Summers SA, Birnbaum MJ, Roth RA . (1996). Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem271: 31372–31378. ArticleCASPubMed Google Scholar
Koul D, Shen R, Bergh S, Lu Y, de Groot JF, Liu TJ et al. (2005). Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther4: 1681–1688. ArticleCASPubMed Google Scholar
Larue L, Bellacosa A . (2005). Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene Rev24: 7443–7454. ArticleCAS Google Scholar
Li G, Robinson GW, Lesche R, Martinez-Diaz H, Jiang Z, Rozengurt N et al. (2002). Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development129: 4159–4170. ArticleCASPubMed Google Scholar
Li Y, Corradetti MN, Inoki K, Guan KL . (2004). TSC2: Filling the GAP in the mTOR signaling pathway. Trends Biochem Sci29: 32–38. ArticlePubMedCAS Google Scholar
Li Y, Podsypanina K, Liu X, Crane A, Tan LK, Parsons R et al. (2001). Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice. BMC Mol Biol2: 2–10. ArticleCASPubMedPubMed Central Google Scholar
Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z et al. (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet16: 64–67. ArticleCASPubMed Google Scholar
Lynch DK, Ellis CA, Edwards PA, Hiles ID . (1999). Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene18: 8024–8032. ArticleCASPubMed Google Scholar
Mackinnon AC, Qadota H, Norman KR, Moerman DG, Williams BD . (2002). C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol12: 787–797. ArticleCASPubMed Google Scholar
Marotta A, Tan C, Gray V, Malik S, Gallinger S, Sanghera J et al. (2001). Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene20: 6250–6257. ArticleCASPubMed Google Scholar
Minobe K, Bando K, Fukino K, Soma S, Kasumi F, Sakamoto G et al. (1999). Somatic mutation of the PTEN/MMAC1 gene in breast cancers with microsatellite instability. Cancer Lett144: 9–16. ArticleCASPubMed Google Scholar
Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ et al. (1999). Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem274: 21528–21532. ArticleCASPubMed Google Scholar
Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H et al. (1997). Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet6: 1383–1387. ArticleCASPubMed Google Scholar
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Donner DB . (1999). NF-_κ_B activation by tumor necrosis factor required the Akt serine-threonine kinase. Nature401: 82–85. ArticleCASPubMed Google Scholar
Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J et al. (2000). Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA97: 3207–3212. ArticleCASPubMedPubMed Central Google Scholar
Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D et al. (2001). Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase. Critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem276: 27462–27469. ArticleCASPubMed Google Scholar
Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J . (1997). Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res57: 3657–3659. CASPubMed Google Scholar
Romashkova JA, Makarov SS . (1999). NF-_κ_B is a target of AKT in anti-apoptotic PDGF signaling. Nature401: 86–90. ArticleCASPubMed Google Scholar
Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X et al. (2005). PIK3CA mutations correlate with hormone receptors, node metastasis, and ErbB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res65: 2554–2559. ArticleCASPubMed Google Scholar
Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science304: 554. ArticleCASPubMed Google Scholar
Sarbassov DD, Guertin DA, Ali AM, Sabatini DM . (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science307: 1098–1101. ArticleCASPubMed Google Scholar
Schwertfeger KL, McManaman JL, Palmer CA, Neville MC, Anderson SM . (2003). Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J Lipid Res44: 1100–1112. ArticleCASPubMed Google Scholar
Schwertfeger KL, Richert MM, Anderson SM . (2001). Mammary gland involution is delayed by activated akt in transgenic mice. Mol Endocrinol15: 867–881. ArticleCASPubMed Google Scholar
Sizemore N, Leung S, Stark GR . (1999). Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-_κ_B p65/RelA subunit. Mol Cell Biol19: 4798–4805. ArticleCASPubMedPubMed Central Google Scholar
Stal O, Perez-Tenotio G, Akerberg L, Olsson B, Nordenskjold B, Skoog L et al. (2003). Akt kinases in breast cancer and the results of adjuvant therapy. Breast Cancer Res5: R37–R44. ArticleCASPubMedPubMed Central Google Scholar
Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW . (2000). High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice. Cancer Res60: 3605–3611. CASPubMed Google Scholar
Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH et al. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet15: 356–362. ArticleCASPubMed Google Scholar
Sun M, Wang G, Paciga JE, Feldman RI, Yuan ZQ, Ma X et al. (2001). AKT1/PKB_α_ kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol159: 431–437. ArticleCASPubMedPubMed Central Google Scholar
Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K et al. (2004). Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell5: 79–90. ArticleCASPubMed Google Scholar
Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C et al. (1997). MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res57: 5221–5225. CASPubMed Google Scholar
Thant AA, Nawa A, Kikkawa F, Ichigotani Y, Zhang Y, Sein TT et al. (2000). Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clin Exp Metastasis18: 423–428. ArticleCASPubMed Google Scholar
Toker A, Newton AC . (2000). Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem275: 8271–8274. ArticleCASPubMed Google Scholar
Tschopp O, Yang Z-Z, Brodbeck D, Duemmler B, Hemmings-Mieszczak M, Watanabe T et al. (2005). Essential role of protein kinase B_γ_ (PKB_γ_/Akt3) in postnatal brain development, but not for glucose homeostasis. Development132: 2943–2954. ArticleCASPubMed Google Scholar
Tu Y, Huang Y, Zhang Y, Hua Y, Wu C . (2001). A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol153: 585–598. ArticleCASPubMedPubMed Central Google Scholar
Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D et al. (2002). Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med8: 1136–1144. ArticleCASPubMed Google Scholar
Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H . (2006). Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA103: 1480–1485. ArticleCASPubMedPubMed Central Google Scholar
West KA, Castillo SS, Dennis PA . (2002). Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Update5: 234–248. ArticleCAS Google Scholar
White DE, Cardiff RD, Dedhar S, Muller WJ . (2001). Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene20: 7064–7072. ArticleCASPubMed Google Scholar
Wu C, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Goicoechea S et al. (1998). Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem273: 528–536. ArticleCASPubMed Google Scholar
Yamaji S, Suzuki A, Sugiyama Y, Koide Y, Yoshida MKH, Mohri H et al. (2001). A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction. J Cell Biol153: 1251–1264. ArticleCASPubMedPubMed Central Google Scholar
Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A . (2005). Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell20: 539–550. ArticleCASPubMed Google Scholar
Younes MN, Kim S, Yigitbasi OG, Mandal M, Jasser SA, Dakak Yazici Y et al. (2005). Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol Cancer Ther4: 1146–1156. ArticleCASPubMed Google Scholar
Zervas CG, Brown NH . (2002). Integrin adhesion: when is a kinase a kinase? Curr Biol152: R350–R351. Article Google Scholar
Zervas CG, Gregory SL, Brown NH . (2001). Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane. J Cell Biol12: 1007–1018. Article Google Scholar
Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC . (2001). Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol3: E71–E73. ArticleCAS Google Scholar